GB Patent

GB0106446D0 — Chemical compounds

Assigned to Ligand UK Research Ltd · Expires 2001-05-02 · 25y expired

What this patent protects

Patent listed against Addyi.

Drugs covered by this patent

Addyi (FLIBANSERIN) · Sprout Pharms

Patent Metadata

Patent number: GB0106446D0
Jurisdiction: GB
Classification: —
Expires: 2001-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Ligand UK Research Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.